Sequencing Reagents Market Report
RA02133
Sequencing Reagents Market, by Type (Library Kits, Template Kits, Control Kits, Sequencing Kits, Others.), Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others.), End Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others.), Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation Sequencing): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global sequencing reagents market is estimated to surpass $12,568.8 million by 2027, exhibiting a CAGR of 13.7% from 2020 to 2027.
The report provides all-inclusive analysis of global sequencing reagents market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
The report emphasizes current market scenario and future trends of the global sequencing reagents market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global sequencing reagents market.
In addition, the report provides market size and forecast scrutinizing global sequencing reagents market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global sequencing reagents market. In the report, the global sequencing reagents market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover sequencing reagents market landscape in respective regions.
Furthermore, competitive scenario of the global sequencing reagents market is covered in the report. Major players functioning in the global sequencing reagents market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global sequencing reagents market, and others.
RESEARCH METHODOLOGY
The research report is drafted by in-house research analysts who sincerely examine the market scenario and form predictions. The market forecasts specified in the report have been derived using proven research approaches and analytical models & tools. The use of such pioneering and effective tools helps market analysts in analyzing, filtering, and providing highly precise statistics and estimates. The report provides an extensive research and analysis backed with factual data obtained from various interviews with market players, reliable and renowned sources of data, and regional intelligence. The insights provided in the report can help investors, stakeholders, and market players to understand investment suitability and seize opportunities for advancements, investments, and partnerships in the global sequencing reagents market.
The research report is formulated by collecting different information, news, and statistics about the sequencing reagents market. For instance, detailed interviews and discussions with veteran market players and stakeholders, including upstream and downstream members have been conducted to obtain reliable and realistic data. Even though primary research forms the crucial part of the research report, secondary research plays a significant role in backing the research outcomes. Nearly 5,900 product type literatures, business magazines, company annual reports, and other such significant documents of leading market players have been considered and studied for thorough understanding of the market scenario. In addition, truthful industry bulletins, medical newsletters, trade associations’ journals, and government websites have been explored for tracking down high-value market insights.
KEY MARKET BENEFITS
- The report provides the market size and predictions for the period from 2019 to 2027
- This report delivers inventions, trends, and innovative developments along with an exhaustive quantitative analysis of the sequencing reagents market during the period of forecast
- The prevailing and forthcoming investment opportunities along with the strategic assessment of the global sequencing reagents market growth is delivered
- The market size and forecasts are derived by scrutinizing market boomers and restraints, and key developments in the sequencing reagents market
- Insights into foremost market players, Porter’s Five Analysis, and top winning business strategies is provided
- Growth tactics and initiatives taken by the top market players are outlined to understand the competitive scenario and strength of the market
KEY MARKET SEGMENTS
The report segments the global market into type ,application ,end use ,technology and region.
- Type: Library Kits, Template Kits, Control Kits, Sequencing Kits, Others.
- Application: Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others.
- End Use: Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others.
- Technology: Sanger Sequencing, Next-Generation Sequencing, Third Generation Sequencing
Regionally, the report evaluates the global market across North America, Europe, Asia Pacific, and LAMEA.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The global sequencing reagents market is consolidated with the presence of large number of key players. These players are increasingly focusing on innovation, geographical expansion of product portfolios, and novel developments to obtain a competitive edge in the market space. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.
Players in global sequencing reagents market include:
1. Thermo Fisher Scientific, Inc.
2. Illumina
3. Inc.
4. QIAGEN
5. BGI
6. Pacific Biosciences of California, Inc.
7. F. Hoffmann-La Roche AG
8. Oxford Nanopore Technologies
9. Agilent Technologies, Inc.
10. Fluidigm Corporation
11. ArcherDX
12. Inc.
13. Takara Bio Inc.
14.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Sequencing Reagents Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Sequencing Reagents Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Sequencing Reagents Market, By Distribution Channel
5.1. Overview
5.2 Library Kits
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Template Kits
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Control Kits
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Sequencing Kits
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Others.
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Research Dive Exclusive Insights
5.7.1 Market attractiveness
5.7.2 Competition heatmap
-
6. Sequencing Reagents Market, By Device Type
6.1. Overview
6.2 Oncology
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Reproductive Health
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Clinical Investigation
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Agrigenomics & Forensics
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Others.
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
-
7. Sequencing Reagents Market, By Type
7.1. Overview
7.2 Academic Research
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Clinical Research
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Hospitals & Clinics
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Pharmaceutical & Biotechnology Companies
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Others.
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Research Dive Exclusive Insights
7.7.1 Market attractiveness
7.7.2 Competition heatmap
-
8. Sequencing Reagents Market, By Type Of Vaccine
8.1. Overview
8.2 Sanger Sequencing
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 Next-Generation Sequencing
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Third Generation Sequencing
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Research Dive Exclusive Insights
8.5.1 Market attractiveness
8.5.2 Competition heatmap
9. Sequencing Reagents Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.1.1.2 Market size analysis, By Device Type, 2020-2027
9.1.1.3 Market size analysis, By Type, 2020-2027
9.1.1.4 Market size analysis, By Type of Vaccine, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.1.2.2 Market size analysis, By Device Type, 2020-2027
9.1.2.3 Market size analysis, By Type, 2020-2027
9.1.2.4 Market size analysis, By Type of Vaccine, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.1.3.2 Market size analysis, By Device Type, 2020-2027
9.1.3.3 Market size analysis, By Type, 2020-2027
9.1.3.4 Market size analysis, By Type of Vaccine, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.1.2 Market size analysis, By Device Type, 2020-2027
9.2.1.3 Market size analysis, By Type, 2020-2027
9.2.1.4 Market size analysis, By Type of Vaccine, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.2.2 Market size analysis, By Device Type, 2020-2027
9.2.2.3 Market size analysis, By Type, 2020-2027
9.2.2.4 Market size analysis, By Type of Vaccine, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.3.2 Market size analysis, By Device Type, 2020-2027
9.2.3.3 Market size analysis, By Type, 2020-2027
9.2.3.4 Market size analysis, By Type of Vaccine, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.4.2 Market size analysis, By Device Type, 2020-2027
9.2.4.3 Market size analysis, By Type, 2020-2027
9.2.4.4 Market size analysis, By Type of Vaccine, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.5.2 Market size analysis, By Device Type, 2020-2027
9.2.5.3 Market size analysis, By Type, 2020-2027
9.2.5.4 Market size analysis, By Type of Vaccine, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By Distribution Channel, 2020-2027
9.2.6.2 Market size analysis, By Device Type, 2020-2027
9.2.6.3 Market size analysis, By Type, 2020-2027
9.2.6.4 Market size analysis, By Type of Vaccine, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.1.2 Market size analysis, By Device Type, 2020-2027
9.3.1.3 Market size analysis, By Type, 2020-2027
9.3.1.4 Market size analysis, By Type of Vaccine, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.2.2 Market size analysis, By Device Type, 2020-2027
9.3.2.3 Market size analysis, By Type, 2020-2027
9.3.2.4 Market size analysis, By Type of Vaccine, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.3.2 Market size analysis, By Device Type, 2020-2027
9.3.3.3 Market size analysis, By Type, 2020-2027
9.3.3.4 Market size analysis, By Type of Vaccine, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.4.2 Market size analysis, By Device Type, 2020-2027
9.3.4.3 Market size analysis, By Type, 2020-2027
9.3.4.4 Market size analysis, By Type of Vaccine, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.5.2 Market size analysis, By Device Type, 2020-2027
9.3.5.3 Market size analysis, By Type, 2020-2027
9.3.5.4 Market size analysis, By Type of Vaccine, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By Distribution Channel, 2020-2027
9.3.6.2 Market size analysis, By Device Type, 2020-2027
9.3.6.3 Market size analysis, By Type, 2020-2027
9.3.6.4 Market size analysis, By Type of Vaccine, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.1.2 Market size analysis, By Device Type, 2020-2027
9.4.1.3 Market size analysis, By Type, 2020-2027
9.4.1.4 Market size analysis, By Type of Vaccine, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.2.2 Market size analysis, By Device Type, 2020-2027
9.4.2.3 Market size analysis, By Type, 2020-2027
9.4.2.4 Market size analysis, By Type of Vaccine, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.3.2 Market size analysis, By Device Type, 2020-2027
9.4.3.3 Market size analysis, By Type, 2020-2027
9.4.3.4 Market size analysis, By Type of Vaccine, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.4.2 Market size analysis, By Device Type, 2020-2027
9.4.4.3 Market size analysis, By Type, 2020-2027
9.4.4.4 Market size analysis, By Type of Vaccine, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By Distribution Channel, 2020-2027
9.4.5.2 Market size analysis, By Device Type, 2020-2027
9.4.5.3 Market size analysis, By Type, 2020-2027
9.4.5.4 Market size analysis, By Type of Vaccine, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Illumina
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Inc.
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 QIAGEN
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 BGI
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Pacific Biosciences of California, Inc.
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 F. Hoffmann-La Roche AG
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Oxford Nanopore Technologies
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Agilent Technologies, Inc.
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 Fluidigm Corporation
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
11.11 ArcherDX
11.11.1 Overview
11.11.2 Business segments
11.11.3 Product portfolio
11.11.4 Financial performance
11.11.5 Recent developments
11.11.6 SWOT analysis
11.12 Inc.
11.12.1 Overview
11.12.2 Business segments
11.12.3 Product portfolio
11.12.4 Financial performance
11.12.5 Recent developments
11.12.6 SWOT analysis
11.13 Takara Bio Inc.
11.13.1 Overview
11.13.2 Business segments
11.13.3 Product portfolio
11.13.4 Financial performance
11.13.5 Recent developments
11.13.6 SWOT analysis
11.14
11.14.1 Overview
11.14.2 Business segments
11.14.3 Product portfolio
11.14.4 Financial performance
11.14.5 Recent developments
11.14.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
